The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

BACKGROUND: Autologous bone marrow-derived stem cells have been ascribed an important therapeutic role in No-Option Critical limb Ischemia (NO-CLI). One primary endpoint for evaluating NO-CLI therapy is major amputation (AMP), which is usually combined with mortality for AMP-free survival (AFS). Onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoit, Eric, O'Donnell, Thomas F, Iafrati, Mark D, Asher, Enrico, Bandyk, Dennis F, Hallett, John W, Lumsden, Alan B, Pearl, Gregory J, Roddy, Sean P, Vijayaraghavan, Krishnaswami, Patel, Amit N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191337/
https://www.ncbi.nlm.nih.gov/pubmed/21951607
http://dx.doi.org/10.1186/1479-5876-9-165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191337/
https://www.ncbi.nlm.nih.gov/pubmed/21951607
http://dx.doi.org/10.1186/1479-5876-9-165

Ejemplares similares